...
【24h】

Peritoneal dialysis for management of pediatric acute renal failure.

机译:腹膜透析治疗小儿急性肾功能衰竭。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: While the use of continuous renal replacement therapies in the management of children with acute renal failure (ARF) has increased, the role of peritoneal dialysis (PD) in the treatment of pediatric ARF has received less attention. DESIGN: Retrospective database review of children requiring PD for ARF over a 10-year period. SETTING: Pediatric intensive care unit at a tertiary-care referral center. PATIENTS: Sixty-three children without previously known underlying renal disease who required PD for treatment of ARF. RESULTS: Causes of ARF were congestive heart failure (27), hemolytic-uremic syndrome (13), sepsis (10), nonrenal organ transplant (7), malignancy (3), and other (3). Mean duration of PD was 11 +/- 13 days. Children with ARF were younger (30 +/- 48 months vs 88 +/- 68 months old, p < 0.0001) and smaller (11.9 +/- 15.9 kg vs 28 +/- 22 kg, p < 0.0001) than children with known underlying renal disease who began PD during the same time period. Percutaneously placed PD catheters were used in 62% of children with ARF, compared to 4% of children with known renal disease (p < 0.0001). Hypotension was common in patients with ARF (46%), which correlated with a high frequency of vasopressor use (78%) at the time of initiation of PD. Complications of PD occurred in 25% of patients, the most common being catheter malfunction. Recovery of renal function occurred in 38% of patients; patient survival was 51%. CONCLUSIONS: Peritoneal dialysis remains an appropriate therapy for pediatric ARF from many causes, even in severely ill children requiring vasopressor support. Such children can be cared for without the use of more expensive and technology-dependent forms of renal replacement therapies.
机译:背景:虽然在连续性肾脏替代疗法中治疗儿童急性肾衰竭(ARF)的使用有所增加,但是腹膜透析(PD)在儿科ARF治疗中的作用却受到较少的关注。设计:回顾性数据库回顾了10年期间需要PD进行ARF的儿童。地点:三级转诊中心的儿科重症监护室。患者:六十三名以前没有潜在的肾脏疾病的儿童,他们需要用PD治疗ARF。结果:ARF的原因是充血性心力衰竭(27),溶血尿毒综合征(13),败血症(10),非肾器官移植(7),恶性肿瘤(3)和其他(3)。 PD的平均持续时间为11 +/- 13天。患有ARF的儿童比已知的儿童年轻(30 +/- 48个月vs 88 +/- 68个月,p <0.0001),更小(11.9 +/- 15.9 kg vs 28 +/- 22 kg,p <0.0001)在同一时期开始PD的潜在肾脏疾病。 62%的ARF儿童使用经皮放置的PD导管,相比之下,已知肾脏疾病的儿童为4%(p <0.0001)。低血压在ARF患者中很常见(46%),这与PD发作时使用升压药的频率高(78%)有关。 25%的患者发生PD并发症,最常见的是导管功能不全。 38%的患者出现肾功能恢复;患者生存率为51%。结论:腹膜透析仍然是多种原因引起的儿科ARF的合适治疗方法,即使是在需要血管加压药支持的重症儿童中也是如此。无需使用更昂贵且技术依赖的肾脏替代疗法即可照顾此类儿童。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号